Journal article
Association of metformin with breast cancer incidence and mortality in patients with type 2 diabetes: a GRADE assessed systematic review and meta-analysis
Abstract
Background: Preclinical data suggest that metformin may reduce breast cancer incidence and improve cancer prognosis. However, the current evidence in observational studies is inconclusive. A systematic review and meta-analysis was conducted to assess the effect of metformin on the incidence of breast cancer and all-cause mortality in patients with type II diabetes (T2D).Methods: A literature search was performed on Medline, EMBASE, and the …
Authors
Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
Journal
Cancer Epidemiology Biomarkers & Prevention, Vol. 27, No. 6,
Publisher
American Association for Cancer Research (AACR)
Publication Date
June 1, 2018
DOI
10.1158/1055-9965.epi-17-0936
ISSN
1055-9965